Skip to main content

Millipore Acquires Remaining Interest in India JV

NEW YORK (GenomeWeb News) – Millipore today said that it has acquired the remaining 60 percent interest of its joint venture In India for an undisclosed sum.

The purchase of Millipore India is in line with the firm's strategy to expand its presence in Brazil, Russia, India, China, and Singapore, it said.

"By establishing direct operations in the country, we will be able to more effectively execute our strategy and leverage our unique capabilities to accelerate growth and support our growing customer base in this dynamic market," Millipore Chairman and CEO Martin Madaus said in a statement.

The subsidiary is based in Bangalore and carries out sales, service, and manufacturing activities targeting the life science and biotech industries in the country. It employs around 300 people and its revenues are split evenly between Millipore's Bioprocess and Bioscience divisions.

Millipore said that the acquisition would have a minimal impact on its 2009 earnings per share but is expected to be accretive in future years due to the elimination of the non-controlling interest.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.